WORLD FEDERATION OF HEMOPHILIA

WFH 2014 World Congress

 

11-15 May 2014 Melbourne
Close
N. Poster
Poster title
Applicant name
Status
  1-P-W Non-clinical immunogenicity assessment of a new recombinant porcine sequence FVIII (OBI-1) Peter Allacher Received Received
  1-MP-M A WEB SITE TO IMPROVE MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT: RESULTS AT 2 YEARS Annarita Tagliaferri Received Received
  1-MP-W Superiority of Prophylaxis vs On-Demand Therapy With Plasma Protein-Free Recombinant Factor VIII Formulated with Sucrose (BAY 81-8973): LEOPOLD II Study Results Kaan Kavakli Received Received
  1-P Products registry Mark Brooker Received Received
  1-MP-T Donor Variation in the Interaction of Activated Recombinant Factor VII (rFVIIa) with Human Platelets and Detection of a High rFVIIa Binding Subpopulation Michael Dockal Received Received
  1-P-T Efficacy and safety of Wilfactin administered by continuous intravenous infusion in severe von Willebrand disease patients undergoing major surgery Franoise BRIDEY Received Received
  2-MP-T iTRAQ strategy to quantify and identify phosphorylation level of biologically active human factor IX used for the treatment of hemophilia B Nathalie ENJOLRAS Received Received
  2-P-T Is switching from a pdFIX (Immunine) to a rFIX (Bax326) safe? Miranda Chapman Received Received
  2-MP-M Quantitative and qualitative mRNA analysis in a severe Haemophilia A patient with high F8 expression and no active FVIII protein Behnaz Pezeshkpoor Received Received
  2-MP-W Identifying prophylactic regimens in young children with Heamophilia A Annelies Nijdam Received Received
  3-P-M Thrombin Generation Capacity And Bleeding Phenotype In Carriers Of Hemophilia A Fariba Baghaei Received Received
  3-MP-T Evaluation of the toxicology and pharmacokinetics of recombinant factor VIII Fc (rFVIIIFc) fusion protein in animals James Scanlon Received Received
  3-P-T Recombinant factor IX (BAX326) in pediatric PTPs with hemophilia B: a prospective clinical trial Miranda Chapman Received Received
  3-MP-M Population pharmacokinetics of plasma-derived factor IX Ari Brekkan Viggosson Received Received
  3-MP-W Co-localization analysis of pathological FXIIIB subunit mutants confirm an indirect but varied effect on secretion. Anne Thomas Received Received
  4-P-T The role of VWF in FVIII/VWF concentrates: biochemical characterization of three different plasma-derived factor VIII products Raimondo De Cristofaro Received Received
  4-MP-W GGCX Splice-Site Mutations: Functional Investigation in a chimeric Minigene System Matthias Watzka Received Received
  4-P-M The use of BclI Restriction Fragment Length Polymorphism for Hemophilia A carrier detection in Sudanese families Rayan Elsheikh Received Received
  4-MP-T Clinical presentation of inhibitor development in nonsevere haemophilia A: more than half of the patients have high titre inhibitors and present with bleeding complications Corien Eckhardt Received Received
  4-MP-M Ultrasonography of joints and correlation with function in Haemophilic Arthropathy in children and young adults - interim results of a clinical pilot trial (HmarthroSonoPilot) Michael Sigl-Kraetzig, MD Received Received
  5-P-W Acquired Factor VIII Inhibitors in the Postpartum Period Anastazia Keegan Received Received
  5-MP-W Assessment of Patient Preferences and Perceived Value of the Comprehensive Interdisciplinary Combined Hemophilia and Orthopedic Clinic Using a Validated Questionnaire. Karen Strike Received Received
  5-P-M Profile of suspected women carriers for Haemophilia-A in a new haemophilia centre NARESH GUPTA Received Received
  5-MP-T An indirect comparison of the efficacy of prophylactic use of rFIXFc and other rFIX products and simulation of the effect of compliance on effectiveness James Scanlon Received Received
  5-MP-M Preference-based Measures of Health-related Quality of Life for Adults with Severe Hemophilia: Implications for the Cost-effectiveness of Prophylaxis Shraddha Chaugule Received Received
  6-MP-W Knowledge and attitudes of pain management in US hemophilia providers Michelle Witkop Received Received
  6-P-M How we address support needs and hereditary issues in Japanese hemophilic carriers? Narrative case study based on semi-structured interviews (A pilot). Akiko Kakinuma Received Received
  6-MP-T The Australian Framework for Management of Bleeding Disorders Michael Stone Received Received
  6-P-W Acquired Hemophilia A with Immune Thrombocytopenia in Adolescent Patient Hyo Sun Kim Received Received
  6-MP-M Associations between clinical outcomes, healthcare resources utilization,and quality of life among patients with severe hemophilia A treated withBayers sucrose-formulated recombinant factor VIII (rFVIII-FS) Sneha Kelkar Received Received
  7-P-W THE TREATMENT OF ACQUIRED HAEMOPHILIA A IN ELDERLY: LOST GAME OR WINNING COMBINATION? Danijela Lekovic Received Received
  7-MP-T Hemophilia Summer Camp: Learning Through Fun & Games in a Digital World Lori Laudenbach Received Received
  7-P-M Life events, support taking experiences and health readiness; psychosocial difficulties among hemophilic carriers in Japan (A pilot). Toshiya Kuchii Received Received
  7-MP-W Psychosocial Problems in Pediatric Patients with Hemophilia Rungrote Natesirinilkul Received Received
  7-MP-M Predictors of Quality of Life among Adolescent and Young Adults with a Bleeding Disorder John McLaughlin Received Received
  8-MP-M Health-Related Quality of Life Data Changes From Baseline Using Haem-A-QoL Scores in the A-LONG Clinical Study of Recombinant Factor VIII Fc Fusion Protein James Scanlon Received Received
  8-P-T The biological activity of GlycoPEGylated recombinant FIX (N9-GP) is similar in two-stage chromogenic assays, in Synthafax-based one-stage clot assay and in TEG assay using blood from Haemophilia B patients Pernille Kaae Holm Received Received
  8-MP-W Multidisciplinary care for women with inherited bleeding disorders; virtual made real. Thibeault Catherine Received Received
  8-P-W Acquired hemophilia postpartum MESSAOUDI REDA Received Received
  8-P-M Noninvasive prenatal diagnosis for early detection of fetal sex in X-linked disorders. Silvia Linari Received Received
  8-MP-T How men with haemophilia manage their home treatment an interactive workshop Chris Harrington Received Received
  9-P-M Characteristics of hemophilia carriers in clinic and testing in National Institute of Hematology and Blood Transfusion, Hanoi, Vietnam Nguyen Thi Mai Received Received
  10-P-W Pharmacokinetics of OBI-1, a recombinant porcine sequence FVIII product, in macaques and hemophilic dogs Alexandra Schiviz Received Received
  10-P-M Factor IX levels in an unselected population of mothers of Haemophilia B patients Mattia Rizzi Received Received
  11-P-T Evaluation of the Safety and Efficacy of Recombinant Factor IX (nonacog alfa) in Japanese Patients with Hemophilia B - The Second Interim Analysis of 304 patients in Post Marketing Surveillance Study Karumori Toshiyuki Received Received
  11-P-M A total management system of carrier diagnosis for hemophilia using gene analysis: results of 24 individuals in 15 Japanese families with hemophilia Keiko Shinozawa Received Received
  11-P-W Efficacy of OBI-1, a recombinant porcine sequence FVIII product, in animal models of hemophilia A Alexandra Schiviz Received Received
  12-P-M INFLUENCE OF PSYCHOLOGICAL AND SOCIAL FACTORS ON HEALTH-RELATED QUALITY OF LIFE IN CARRIERS OF HEMOPHILIA Cornelia Wermes Received Received
  12-P-W Preclinical safety of OBI-1, a recombinant porcine sequence FVIII product Alexandra Schiviz Received Received
  12-P-T Assessment of Incremental Recovery Over Time in Postauthorization Safety Surveillance Study (PASS) of Hemophilia A Patients Switching from Moroctocog alfa or Other Factor VIII Products to Moroctocog alfa Albumin Free Cell Culture ( AF-CC) Joan Korth-Bradley Received Received
  13-P-W Acquired Factor VIII inhibitor in Children: Experience in a Single Institute Darintr Sosothikul Received Received
  13-PO-M The bleeding symptom of women in the Japanese hemophilia families Kayo Inoue Received Received
  13-P-T In-vitro characterisation of the first therapeutic factor V concentrate Andrew Lawrie Received Received
  14-P-M Vitamin D Levels in Patients with Severe Hemophilia A davut albayrak Received Received
  14-P-W Acquired Hemophilia A: Presentation of 5 cases Svetlana Stankovic Received Received
  15-P-W Effect of OBI-1, a recombinant FVIII product with porcine FVIII sequence, on thrombin generation and clot structure in plasma from hemophilia A patients with inhibitors Peter Turecek Received Received
  15-P-M Using BeneFIX for Low-Dose Surgical Prevention in Chinese Patient with Hemophilia B: a Case Report Xiangshan Cao Received Received
  16-P-M Body Mass Index-dependent Pharmacokinetic Analysis of an Investigational Recombinant Factor IX Product, IB1001 (trenonacog alfa) and a Commercial Factor IX product, Nonacog Alfa (BeneFIX) in Hemophilia B Patients Bojan Drobic Received Received
  16-P-T Safety and efficacy of a new high purity factor X concentrate in subjects with factor X deficiency undergoing surgery Miranda Norton Received Received
  16-PO-W Lupus anticoagulant detected in a patient with acquired haemophilia A Masato Bingo Received Received
  17-P-T Octaplex state-of-the-art: implementation of a new nanofilter Barbara Stadlmair Received Received
  17-P-M Splenic injury in hemophilic patient without abdominal trauma NIVIA FOSCHI Received Received
  17-PO-W Report of a case of acquired hemophilia adolfo manuel gaona tottil Received Received
  18-P-W Aging with Hemophilia: Enhancing Dialogue with Our Patients Erin Couch Received Received
  18-P-M Screening for Intracranial Haemorrhage Following Birth in Neonates with Severe Haemophilia elizabeth jones Received Received
  18-P-T Validation of a population pharmacokinetic model of recombinant factor VIII in boys with Haemophilia A John Roy Received Received
  19-P-W The Elderly Hemophilia population A Nordic patient organization perspective Gruszka Zygmunt Received Received
  19-P-T Safety of BAX 855, a polyethylene glycol (PEG) conjugated full-length recombinant Factor VIII product Alexandra Schiviz Received Received
  19-P-M Usefulness of ISTH Bleeding assessment tool in the prediction of bleeding disorders in suspected patients referred to a tertiary care hospital in India Annamma Kurien Received Received
  21-P-W Multivariate analysis of the occurrence of intracranial hemorrhage among adult hemophiliacs in Japan Masashi Taki Received Received
  21-P-M Different Clinical Phenotype Between Hemophilia B And Hemophilia A: Results Of Global Coagulation Assays. Maria Elisa Mancuso Received Received
  22-P-T High-purity, plasma-derived, pasteurized Factor VIII concentrate in the treatment of patients with haemophilia A: update of a long-term pharmacovigilance Patrick Sommerer Received Received
  22-P-W Risk Assessment for Coronary Heart Disease in Adult Patients with Hemophilia is Influenced by Hepatitis C Status. Annette von Drygalski Received Received
  23-P-T PHARMACOKINETIC PROPERTIES, SAFETY AND TOLERABILITY OF NEW B-DOMAIN DELETED RECOMBINANT FACTOR VIII (OCTOFACTOR) IN PATIENTS WITH SEVERE AND MODERATELY SEVERE HEMOPHILIA A Anton Borozinets Received Received
  23-P-M Iliopsoas haematoma in patients with haemophilia: a single-center study Daniela Neme Received Received
  23-P-W Point prevalence estimates of comorbidities among people with hemophilia using a large commercial insurance database Tami Wisniewski Received Received
  24-PO-T Recombinant-activated factor VII (rFVIIa) for control of haemorrhage in thrombocytopenic patients (pts) Gennadii Galstian Received Received
  24-P-W Co-morbidities and HIV Infection of Hemophiliacs in Taiwan: A Population-Based Study Chia-Yau Chang Received Received
  25-P-W Essential thrombocythemia and acquired von Willebrand syndrome in patent with severe haemophlia B Krzysztof Chojnowski Received Received
  25-P-M Epidemiological and clinical profile of hemophilia in Madagascar Aimée Olivat Rakoto Alson Received Received
  25-PO-T Recombinant or plasma derived factor concentrates attitudes of patients in Germany Christina Mondorf Received Received
  26-P-M Hematospermia has been experienced by one-third of hemophilia patients chie sato Received Received
  27-PO-T Comparative Analysis of Single Vial Dosing Options Among Recombinant FVIII Products in the US Elizabeth Schwartz Received Received
  27-P-W Single joint bleeding episode in factor VIII deficient mice causes acute osteoarthritic degradation two-weeks post injury, which is prevented with aggressive factor replacement Anthony Lau Received Received
  28-P-T Continues ITI versus prophylaxis with NovoSeven; An immune tolerance induction failure cost analysis model. Chris Barnes Received Received
  28-P-W Recent causes of death in people with haemophilia in New Zealand Chantal Lauzon Received Received
  28-P-M A survey on treatment and quality of life (QoL) of hemophilia A (HA) and hemophilia B (HB) children in Zhejiang Province in Southern China Weiqun Xu Received Received
  29-P-W Evaluation Of Kidney Function In Young Haemophilics Nihal Ozdemir Received Received
  29-P-M To evaluate Circumcision practices and outcome in undiagnosed patients of factor VIII and factor IX deficiency in Pakistan TAHIRA ZAFAR Received Received
  29-P-T Low incidence of FVIII inhibitors in patients treated with plasma derived FVIII concentrates and the outcomes of immune tolerance induction with FVIII/vWF concentrates Angelika Batorova Received Received
  30-P-T Uptake and timing of inhibitor screening in non-severe haemophilia A: results of a pan-London evaluation Paul Batty Received Received
  30-PO-M Coronary Artery Bypass Surgery in Patients with Congenital Factor Deficiency: Single Centre Experience M.CEM AR Received Received
  31-PO-M Effect of co-inheritance of Factor V Leiden mutation in a family of inherited Hemophilia A with severe disease NAMRATA AWASTHI Received Received
  31-P-T Slovenian National data for inhibitor appearance in haemophilia A (HA) patients majda benedik dolnicar Received Received
  31-PO-W Prevalence of morbidity and mortality among patients with hereditary bleeding disorders in southern Iran: A 15 years experience Mehran Karimi Received Received
  32-PO-M Mortality in Cuban hemophiliacs patients. Dunia Castillo Received Received
  33-PO-M Benefits of conventional and yoga therapy rohini dange Received Received
  33-P-W Improvement of Coagulation by Inhibition of Cellular Tissue Factor Pathway Inhibitor Michael Dockal Received Received
  34-P-W Design of an Efficient Inhibitor of TFPI by Molecular Fusion of Two Inhibitory Peptides Improves Coagulation in Hemophilia Michael Dockal Received Received
  34-PO-M Evaluation of heart function in patients with hemophilia Mehran Karimi Received Received
  35-P-T Selection and characterization of single-chain variable antibody fragments (scFvs) specific for anti-FVIII antibodies Kerstin Brettschneider Received Received
  35-P-W In-vivo efficacy of human recombinant Factor IX produced by the Hepatoma cell line HuH-7 Nathalie ENJOLRAS Received Received
  35-PO-M Central nervous system bleeding in hemophiliacs: experience in single center Tunisia olfa kassar Received Received
  36-PO-M Descriptive epidemiology of hemophilia in a Tunisian Center olfa kassar Received Received
  36-P-T A Status of Immune Suppression in Hemophilia A with Developed Factor VIII Inhibitors. Zhenping Chen Received Received
  36-P-W Nanobody-induced stabilization of TAFIa activity improves resistance of hemophilia A clots against premature fibrinolysis Maarten Hendrickx Received Received
  37-P-W A Novel Semisynthetic Activatable Factor VII Comprising an Optimal Synthetic Thrombin Cleavage Site and a Self-immolative Linker Vu Hong Received Received
  37-P-T The Development of Anti-Factor VIII Antibodies Associated with the Change of Serum BAFF Level in Hemophilia A mice Shin-Nan Cheng Received Received
  37-PO-M Is every tumor in hemophilia patients pseudotumor? Mihailo Smiljanic Received Received
  38-P-T Natural course of inhibitors in Korean Hemophilia A patients Eun Jin Choi Received Received
  38-PO-M Haemophilia Presenting with Subgaleal Haemorrhage in the Neonatal Period: A Case Series Aditi Vedi Received Received
  38-P-W In Vitro Characterization of ACE910, a Humanized Bispecific Antibody to Factors IXa and X Tetsuhiro Soeda Received Received
  39-P-W Reversal of anticoagulants directly inhibiting FXa or thrombin (NOAC) by FEIBA can be monitored by thrombin generation assay Peter Turecek Received Received
  39-P-T The association of factor VIII genotypes and HLA DRB115, tumor necrosis factor -308A and interleukin -10-1082G alleles on inhibitor development in Thai patients with hemophilia A Ampaiwan Chuansumrit Received Received
  39-PO-M EVALUATING THE EFFICACY OF FACTOR COVER AND OUT COME ON CIRCUMCISION IN HAEMOPHILIC PATIENTS- A NORTHERN PAKISTAN EXPERIENCE TAHIRA ZAFAR Received Received
  40-P-W Interaction of BAX 855, a PEGylated full-length recombinant FVIII, with the FVIII clearance receptor LRP Peter Turecek Received Received
  40-P-T F8 genotype specific inhibitor risks in Argentine patients with severe HA and particular risk estimation of different mutation types. Carlos De Brasi Received Received
  40-P-M Safety Profile of IB1001, Recombinant Factor IX (trenonacog alfa) in the Treatment of Hemophilia B Hugo Astacio Received Received
  41-P-M Home treatment of haemarthrosis with recombinant activated factor VII (rFVIIa) in patients with haemophilia A or B and inhibitors: experience from developing countries Daniel Booth Received Received
  41-P-T Observational Immune Tolerance Induction research program (ObsITI) - a multifaceted approach to explore immune tolerance induction Carmen Escuriola Received Received
  41-P-W Structural and functional characterization of BAX 855, a PEGylated recombinant FVIII Peter Turecek Received Received
  42-P-W Correlation between in vitro activity of human recombinant ADAMTS13 obtained with FRETS-VWF73 assay and assays using full-length VWF as substrate Peter Turecek Received Received
  43-P-W Discrepancy in inhibitor assessment for two acquired TTP patients using a static and a flow-based assay Peter Turecek Received Received
  43-P-M A Clinical Study In Previously Untreated Patients With Severe Haemophilia A - Immunogenicity, Efficacy and Safety Of Treatment With Human-cl rhFVIII Friederike Madee Received Received
  43-P-T Effect of vaccinations on inhibitor development in patients with severe hemophilia A Mojtaba Hashemi Received Received
  44-P-M Latest Results From The PUP-GCP Clinical Trial: A Low Inhibitor Rate In Previously Untreated Patients With Severe Hemophilia A Treated With Octanate Friederike Madee Received Received
  44-P-T Immune monitoring of FVIII inhibitor development in the Hemophilia Inhibitor PUP Study (HIPS) Christoph Hofbauer Received Received
  44-P-W Functional characterization of BAX930, a human recombinant ADAMTS13 drug candidate Peter Turecek Received Received
  45-P-T Inhibitor Eradication in Haemophilia: a European Survey Katharina Holstein Received Received
  45-P-M Safety and effectiveness of anti inhibitor coagulation complex (AICC) in routine clinical management: a post-authorization safety study (PASS) Aaron Novack Received Received
  46-P-W Efficacy and Safety of Concomitantly Administered Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII in Hemophilic Mice Michael Dockal Received Received
  46-P-M Factor VIII continuous infusion in El Salvador, seven years experience Ana Gladys Reyes Received Received
  47-P-W Serratiopeptidase in treating hematomas without surgical drainage in hemophilia, three successful cases Cesar Nolasco Cancino Received Received
  47-P-T The results of late immune tolerance induction in children with severe hemophilia A and inhibitor in Poland Anna Klukowska Received Received
  48-P-T Does a once weekly prophylaxis with low dose factor VIII in PUPs with haemophilia A decrease the risk of inhibitor development? Results of a survey in centers of the Competence Network Hemorrhagic Diatheses East. Ralf Knoefler Received Received
  48-P-W Reversal of the effects of new oral anticoagulants by treatment with FEIBA Alexandra Schiviz Received Received
  49-P-T Rituximab as first-line treatment for the management of adult non-severe hemophilia A patients with inhibitors: A single-center experience Ming Yeong Lim Received Received
  49-P-M What we learn from data of a prospective post-authorization safety surveillance study in 384 hemophilia A patients with antihemophilic factor (recombinant) plasma / albumin free method demonstrates safety and efficacy in Japan MUTSUMI SHIRAISHI Received Received
  50-P-T Bleeding Phenotype And Clinical Management Of Children With Severe Hemophilia A And Inhibitors: A Follow-up Cohort Study. Maria Elisa Mancuso Received Received
  50-P-M EpiNine interim analysis of a non-interventional, multicentre study in patients with haemophilia B Patrick Sommerer Received Received
  50-P-W The TFPI antibody, concizumab, improves thrombin generation in plasma from individuals with haemophilia A, haemophilia B or haemophilia with inhibitors Emily Waters Received Received
  51-P-W Comparison of recombinant factor IX and a glycoPEGylated factor IX (N9-GP) in thrombin generation initiated by either tissue factor or factor XIa Emily Waters Received Received
  51-P-M Real-life clinical experience of 117 previously untreated patients (PUPs) treated with antihemophilic factor (recombinant), plasma/albumin free method in Japanese post authorization safety surveillance MASASHI TAKI Received Received
  51-P-T Elective Orthopaedic Surgery In Patients With Haemophilia And Inhibitors: Still A Big Challenge For Haematologists? Maria Elisa Mancuso Received Received
  52-P-T Evaluation of Safety and Effectiveness of ADVATE in Hemophilia A patients with low titer inhibitors or a personal history of inhibitor. A Meta-analysis of ADVATE Post-Authorization Safety Studies data Maura Marcucci Received Received
  52-P-W Retrospective analysis of 115 patients with haemophilia A in a single medical centre Gonul Aydogan Received Received
  52-P-M Low-dose prophylaxis for Chinese hemophilia children involving maxillary hemophilic pseudotumors Guoxia Yu Received Received
  53-P-W Comparison of historic on-demand versus prospective on-demand and prophylaxis bleeding episodes in hemophilia A and B patients with inhibitors treated with FEIBA NF Jennifer Doralt Received Received
  53-PO-M The Results of Clinical Trial Evaluating of the Efficacy and Safety of Octofactor compared Octanate in the Treatment of Bleeding in Patients with Severe and Moderate Hemophilia A Nina Klimova Received Received
  53-P-T Recurrence of Inhibitors after Immune Tolerance Induction: A Retrospective Single-Center Study Kim Schafer Received Received
  54-P-T Early Elimination of Factor VIII Inhibitor by ITI with High Dose Immunoglobulin in Hemophilia A Children Yoko Mizoguchi Received Received
  54-PO-M RESULTS OF EFFICACY AND SAFETY IN CLINICAL TRIAL ESTIMATED A NEW RECOMBINANT FACTOR VIII (OCTOFACTOR) IN PROPHILACTIC TREATMENT IN PATIENTS WITH SEVERE AND MODERATE HEMOPHILIA A. Anton Borozinets Received Received
  54-P-W A review of recommended factor doses administered and annual bleed rate relative to adherence level in a population with hemophilia A and B Natalie Duncan Received Received
  55-P-W Low dose Factor VIII prophylaxis in children with severe hemophilia Tarun Dutta Received Received
  55-P-T Allergic reaction immediate by IgE in hemophilia A patient using plasma-derived factor VIII concentrate is not against factor VIII protein Silmara Montalvo Received Received
  56-P-T Characteristics of inhibitors in patients with hemophilia in National Institute of Hematology and Blood Transfusion, Hanoi, Vietnam Nguyen Thi Mai Received Received
  57-P-W Individualization of prophylaxis in adults improves bleeding outcomes Shannon Jackson Received Received
  57-P-T Surgery and Invasive procedure with bypassing agents in hemophilic patients with inhibitors : a single center experience Young Shil Park Received Received
  57-P-M Evaluation of the Thrombin Generation Potential of a Recombinant Factor IX Fc Fusion Protein (rFIXFc) in a Phase 3 Multi-national Clinical Trial Yang Buyue Received Received
  58-P-T CONCOMITANT THERAPY OF A HEMOPHILIA-A PATIENT WITH INHIBITOR BY USING LOW DOSE BY-PASS AGENTS Turkan PATIROGLU Received Received
  58-P-M Effect of Recombinant and Plasma-derived von Willebrand Factor on the Procoagulant Activity of Factor VIII in Thrombin Generation Assays Michael Dockal Received Received
  59-P-T Combined (sequential and parallel) therapy with by-passing agents and antifibrinolytics in patients with hemophilia and inhibitor. Nebojsa Rajic Received Received
  59-P-M Differential effects on TFPI levels upon exposure of human endothelial cells to TFPI antibodies Helle Heibroch Petersen Received Received
  59-P-W Severe Hemophilia B Patients Are Prescribed Prophylaxis Less Frequently than Severe Hemophilia A Patients Josh Epstein Received Received
  60-P-W Measuring the Success of iNFUSE: A program to educate and increase adherence to FVIII Treatment Josh Epstein Received Received
  60-P-M Postoperative TGA(Thrombin Generation Assay)monitoring of homeostasis of haemophilia patients with inhibitor fujihiko minamoto Received Received
  60-P-T Postauthorization safety surveillance study (PASS) of hemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings Pablo Rendo Received Received
  61-P-M Reversal of oral anticoagulation by PCC, aPCC and rFVIIa in vitro Ann-Kathrin Pilgrimm-Thorp Received Received
  61-P-T Devastative tongue bleeding due to self-bite after dental extraction in hemophilia patient with inhibitor Ilgen Sasmaz Received Received
  61-P-W Individualized prophylaxis with Human-cl rhFVIII in adult patients with severe haemophilia A Friederike Madee Received Received
  62-P-T Prevalence of Inhibitors in Indian Haemophilia patients Shrimati Shetty Received Received
  63-P-M Visualization of VWF-FVIII-complex formation by single molecule imaging Peter Turecek Received Received
  63-P-T A Phase III clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in hemophilia patients with inhibitors: hemostatic efficacy and safety HIROTOSHI NAKANO Received Received
  64-P-T Prospective ADVATE Immune Tolerance Induction Registry (PAIR) Interim Results: Success Rates Continue to Support Published Literature Katharina Steinitz Received Received
  64-P-W Discontinuing long-term prophylaxis in severe haemophilia: effects on joint health Annelies Nijdam Received Received
  65-P-W Comparing the Cost-effectiveness of aPCC and rFVIIa Prophylaxis Regimen in the Management of Hemophilia Patients with Inhibitors in the US Abiola Oladapo Received Received
  65-P-T Inhibitors increase the burden of disease in nonsevere haemophilia A patients - treatment strategies to obtain haemostasis. Alice van Velzen Received Received
  65-P-M WFH Annual Global Survey: New Integrated Electronic Data Collection and Management System Mark Brooker Received Received
  66-P-W Tailoring Prophylaxis for Peak Performance Michaela Stemberger Received Received
  66-P-M be-Coag, The Internet Heamophilia Medical Record by NMOs Herman De Smet Received Received
  67-P-W Low Bleeding Rates in Youth and Young Adults on Low-Dose Daily Prophylaxis for Severe Hemophilia A. Jean St-Louis Received Received
  68-PO-T Circumcision in hemophilia with inhibitor EMNA GOUIDER Received Received
  69-P-W Factors associated with prophylaxis use in persons with hemophilia in the United States Megan Ullman Received Received
  69-PO-T Two consecutive life threatening bleeding episodes in hemophilia A patients with high responding inhibitors Jung Woo Han Received Received
  70-PO-T Pseudotumor causing duodenal fistula and secondary tumor rupture in a hemophilia B patient with high responding inhibitors : case report Jung Woo Han Received Received
  70-P-W Association of Peak FVIII Levels and AUC with Bleeding in Patients with Hemophilia A on Every Third Day PK-Tailored Prophylaxis Leonard Valentino Received Received
  71-P-W Changing views on the use of prophylaxis in men with severe hemophilia across the age spectrum Ming Yang Received Received
  71-PO-T Evaluation of inhibitor antibody in hemophilia A population. olfa kassar Received Received
  72-PO-T Successful Management of Orthopedic Surgery in a Patient with Congenital Haemophilia A with Inhibitors from Guatemala, Central America. A Case Report Marta Julia Lopez Received Received
  72-P-W The efficacy and safety of low-dose prophylaxis in Chinese haemophilia A children Daisy Yuan Received Received
  72-P-M Community Counts: A National Surveillance System For Bleeding And Clotting Disorders. Kathleen Van Gorden Received Received
  73-PO-T Transcatheter arterial chemoemboliazation of hepatocellular carcinoma: management of one hemophilia A patient with inhibitor Takeshi Matsumoto Received Received
  73-P-M The electronic diary smart medication allows a rapid and comprehensive overview of haemophilia home treatment Wolfgang Mondorf Received Received
  74-PO-W Assessment of children with hemophilia under low doses prophylaxis EMNA GOUIDER Received Received
  74-P-M Causes of death in haemophilia patients in Argentina Daniela Neme Received Received
  74-PO-T Experience of knee and hip replacement in patients with haemophilia with inhibitors Tatyana Polyanskaya Received Received
  75-P-M MyABDR: an online personally controlled clinical tool for recording treatments and bleeds Suzanne OCallaghan Received Received
  76-P-M Real World Utilization and Cost of aPCC versus rFVIIa Among Hemophilia Patients with Inhibitors in the US Abiola Oladapo Received Received
  76-PW Genetics of rare bleeding disorders in the Scottish population David Stirling Received Received
  77-P-W Recurrent venous thromboembolic event in a sever factor X deficient patient without any correlation to Pro-coagulant product. PEYMAN ESHGHI Received Received
  77-PO-W Secondary Prophylaxis in Childhood Factor VII Deficiency Zafer Salcioglu Received Received
  77-PO-T FVIII and FIX inhibitors in people living with hemophilia in Cameroon, Africa. Tayou Tagny Claude Received Received
  77-P-M French online database on bleeding disorders NHEMO: pharmaceutical contributions to the multidisciplinary network. Martine Pennetier Received Received
  78-P-W CONGENITAL FACTOR X DEFICIENCY ASSOCIATION BETWEEN COAGULANT FACTOR ACTIVITY AND CLINICAL BLEEDING SEVERITY IN FOUR CASES Zahra Badiei Received Received
  78-PO-T Severe Haemophilia A with high-titre inhibitors and a complicated clinical course Rajendra Thejpal Received Received
  78-P-M Data and demographics from the Australian Bleeding Disorders Registry (ABDR) Michael Stone Received Received
  79-P-M Australian Bleeding Disorders Registry the evolution over 25 years of a national database for people with bleeding disorders Michael Stone Received Received
  79-PO-T Experience of prophylactic and on demand treatment of inhibitory form of haemophilia B in children using recombinant activated FVII. Vladimir Vdovin Received Received
  80-P-M Data Managers - Pivotal role in documentation of care for people with bleeding disorders in the Australian Bleeding Disorders Database (ABDR) Deirdre Tuck Received Received
  81-P-T Von Willebrand Factor antigen and age explain variation in baseline FVIII:C among nonsevere haemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser) Janneke Loomans Received Received
  81-P-M The Impact of Factor VIII Concentrate on the Development of Inhibitors in Children with Severe Hemophilia A: Turkish PUP Registry Study AYSEGUL UNUVAR Received Received
  82-P-M Use of data and reporting to improve haemophilia care Brian Ramsay Received Received
  82-P-W FGB mutations leading to fibrinogen deficiency: four novel mutations Aurelien Lebreton Received Received
  83-P-M Update of National Hemophilia Registry of China Feng Xue Received Received
  83-P-W Congenital Coagulation Factor VII Deficiency: A Phenotype and Genotype Study in Taiwan Yeu-Chin Chen Received Received
  84-P-T Repair of a bicuspid aortic valve resolved the acquired von Willebrand syndrome in a 17 year-old boy: Bleeding was the only indication for surgery. Maria Avila Received Received
  84-P-W Defective ER retention signal due to mutation VKORC1:p.Arg98Trp results in VKCFD2 Katrin Jeannette Czogalla Received Received
  84-PO-M Congenital bleeding disorders in Golestan province, Iran Narges beigom Mirbehbahani Received Received
  85-P-T Management of Menorrhagia in Von Willebrand Disease Can Balkan Received Received
  85-PO-M Rationale and study design of TARGET H: An observational sTudy to Assess the feasibility of combining data from patient ReGistries in countries with developing healthcare systems to EvaluaTe Haemophilia management Joachim Potgieter Received Received
  85-P-W Long term two central follow up study on a large group of patients with congenital factor XIII deficiency treated prophylactically with Fibrogammin P Akbar Dorgalaleh Received Received
  86-P-W Congenital factor V deficiency, comparison the severity of clinical presentations among patients with rare bleeding disorders Majid Naderi Received Received
  86-PO-M RegHemo: first steps to an Integrated Information System in Hemophilia and other congenital coagulopathies Ariel Triana-Usich Received Received
  86-P-T Age at first bleeding symptom in patients with von Willebrand disease (VWD) eugenia biguzzi Received Received
  87-P-W Molecular analysis, Clinical Manifestations and Management of Factor XIII Deficiency in Southeast of Iran Majid Naderi Received Received
  87-P-M Potency assignment and measurement of recombinant FIX activity in human plasma impact of aPTT reagents on the 1-stage clotting assay Peter Turecek Received Received
  87-P-T Genetic Defect of von Willebrand Disease Patients in Taiwan Yeu-Chin Chen Received Received
  88-P-M Differentiation of hemostatic potency of natural, full length recombinant FVIII molecule from B-domain deleted recombinant FVIII Peter Turecek Received Received
  88-P-W Effective management of surgical procedures of inherited FVII deficient patient six-year experience at University Hospital in Ostrava Radomira Hrdlickova Received Received
  89-P-W Assessment of bleeding phenotype in PT-VWD and other RBDs using electronic bleeding questionnaire (eBQ): a retrospective study on 55 subjects Harmanpreet Kaur Received Received
  89-P-M Comparison of the behavior of different Factor VIII products measured with the chromogenic Factor VIII activity assay and the FVIII one stage clotting assay. Clint van Duren Received Received
  89-P-T Acquired von Willebrand Disease To Treat or Not to Treat the Inhibitor? Susan Curoe Received Received
  90-P-W Successful Treatment of Glanzmanns Thrombasthenia with Recombinant Activated Factor VII NovoSeven Bijan Keikhaei Dehdezi Received Received
  90-P-M The Enhanced Liver Fibrosis (ELF) test compared to transient elastography in haemophilia patients with chronic hepatitis C Greet Boland Received Received
  91-P-M Low Risk Of Hepatic Fibrosis Of Egyptian Severe Hemophilia A Patients With Long Standing Hepatitis C Virus Infection. Mohsen Elalfy Received Received
  91-P-W Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review Sophie Wiewel-Verschueren Received Received
  91-P-T Von Willebrand Factor Modifiers and their effect on Subjects with and without von Willebrand Disease Carsten Detering Received Received
  92-P-T Validity of the Bleeding Score in VWD Patients with Hereditary Thrombophilia Carsten Detering Received Received
  92-P-W THROMBIN GENERATION OF PATIENTS WITH FACTOR XI DEFICIENCY Le Quellec Sandra Received Received
  92-P-M Analysis of the response to interferon-based therapy for hepatitis C virus infection in patients with inherited bleeding disorders during 1992 2012 Takeshi Hagiwara Received Received
  93-P-T Assessment of Factor FVIII Binding Capacity and Affinity of Recombinant von Willebrand Factor of Different Multimer Sizes on Solid Surfaces and in Solution Dockal Michael Received Received
  93-P-W Global Development Plan for a Double Virus Inactivated Fibrinogen Concentrate for the Treatment of Congenital Fibrinogen Deficiency Friederike Madee Received Received
  94-P-T Hysterectomy and endometrial ablation in women with Von Willebrand Disease; a systematic review heleen eising Received Received
  94-P-M SAFETY OF TRIPLE THERAPY WITH TELAPREVIR IN HEPATITIS C EXPERIENCED HAEMOPHILIACS Olga Katsarou Received Received
  95-P-T Different bleeding phenotype in von Willebrand disease type 3 in two siblings caused by additional Antithrombin deficiency Ronald Fischer Received Received
  95-P-W Update on Platelet-type Von Willebrand Disease Registry and Proposed Mechanisms for Newly Reported Mutations Maha Othman Received Received
  95-P-M Natural History of Hepatitis C Virus (HCV) Infection In Korean Hemophiliacs Hugh Kim Received Received
  96-P-T Continuous infusion of a FVIII/VWF concentrate for major surgery in 3 patients with von Willebrand disease Charlotte Grimley Received Received
  96-P-W SINGLE CENTER REGISTRY OF RARE BLEEDING DISORDERS FROM TURKEY Turkan PATIROGLU Received Received
  96-P-M Antiviral Treatment of HCV Infected Young Hemophiliacs An Update of 20 Years Experience - New Expectations to Cure Hepatitis C Katalin KoehlerVajta Received Received
  97-P-T Thrombosis in patients with von Willebrand disease. Experience from a Danish haemophilia center Lone Hvitfeldt Poulsen Received Received
  97-P-M Time for a change: People with Haemophilia and Hepatitis C in New Zealand Chantal Lauzon Received Received
  98-P-M Prevalence and treatment response of hepatitis C in hemophilia patients Ching Yeh Lin Received Received
  98-P-W Congenital factor XIII deficiency in the heterozygous twins MESSAOUDI REDA Received Received
  99-P-M Patient Demographics, HCV-Infection and CD4 Cell Counts in HIV-Infected Haemophilia Patients: Data from the Bonn Haemophilia Care Center Natascha Marquardt Received Received
  99-P-W Thrombocytopenia with a thromboxane A2 pathway and dense granule secretion defect Mattia Rizzi Received Received
  99-P-T Pseudo-acquired VWD in Essential Thrombocythemia: the role of Platelets Stefano Lancellotti Received Received
  100-P-W Factor XIII Deficiency As Underlying Cause Of Unexplained Bleeding MARTA RUIZ MERCADO Received Received
  100-P-T VWF propeptide demonstrates the relationship between antibody-mediated VWF clearance and secretion in a case of acquired von Willebrand Syndrome: Utility for determining remission status Adrienne Lee Received Received
  101-P-M Long-term observation of hemophiliacs with HIV infection in Japan: Follow-up of survival and status of HCV infection Shinobu Tatsunami Received Received
  101-P-W Major Surgical Interventions in Childhood Factor VII Deficiency Salcioglu Zafer Received Received
  101-P-T VWD treatment with a double virus-inactivated VWF/FVIII concentrate (Wilate) a single centre experience from the Hemophilia Foundation in Salta, Argentina Maria Sol Cruz Received Received
  102-P-T Bleeding tendencies and the course of von Willebrand parameters in patients with von Willebrand disease during pregnancy Wolfgang Miesbach Received Received
  102-P-M Prevalence and status of HCV infection among Japanese hemophiliacs Shinobu Tatsunami Received Received
  102-P-W Normalization of ADAMTS13 activity in rats with an adjusted inhibitor titer by administration of recombinant ADAMTS13 Alexandra Schiviz Received Received
  103-PO-M Prevalence of Transfusion-transmitted viral infections in hemophiliacs olfa kassar Received Received
  103-P-T Is the von Willebrand factor deficiency in patients with Gaucher disease acquired? Mirjana Mitrovic Received Received
  103-P-W A case of severe factor XIII deficiency with an unusual uniparental disomy heredity Ming-Ching Shen Received Received
  104-P-T Dental Management of the Patient with von Willebrand Disease Rebecca Schaffer Received Received
  104-P-W Familial vitamin K clotting factor deficiencies (VKCFD) in an infant with novel mutation in Gamma-glutamyl carboxylase (GGCX) gene Mrs.Nongnuch Sirachainan Received Received
  104-PO-M Infectious markers among Cameroonians living with haemophilia Tayou Tagny Claude Received Received
  105-P-W A case of factor X (FX) deficiency caused by novel mutations Q56K, Q104X Jaewoo Song Received Received
  106-P-M Improved strategy for rapid genetic analysis of hemophilia A Rima Dardik Received Received
  106-P-W Factor VII Deficiency Patients: 5 Years Factors Concentrates Utilization Trend based on the Canadian Hemophilia Assessment and Resource Management System (CHARMS) Aicha TRAORE Received Received
  107-P-T Investigation of the interaction between VWF propeptide and highly multimerized therapeutic rVWF and its influence on FVIII stabilization Peter Turecek Received Received
  107-P-W An Infant Presented With Deficiencies Of Vitamin K Dependent Factors Due To An Inherited Novel Mutation In GGCX Gene SULE UNAL Received Received
  108-P-T Determination of the VWF activity with the ristocetin independent gain of function Glycoprotein 1b Innovance von Willebrand Activity Assay. Clint van Duren Received Received
  108-P-M Investigation Of A Prolonged APTT Different Approaches Adopted By Participants In The WFH External Quality Assessment Programme Ian Jennings Received Received
  108-P-W Prophylactic therapy with fibrinogen concentrate prevents recurrent pain episodes, but not radiological deterioration, in two cases having bone cysts as a rare complication of afibrinogenemia Monique van Meegeren Received Received
  109-P-M Underfilled Blood samples: An important source of error and improved detection using an automated sample volume check on Sysmex CS Analysers Anita Woolley Received Received
  109-P-T A synonymous variant in the VWF which induces intron retention causes VWD phenotype Hamideh Yadegari Received Received
  109-PO-W Experience in Circumcision of Congenital Factor X Deficiency Patients Sinan Akbayram Received Received
  110-P-M Evaluation of the new Q Smart analyzer from Grifols for initial investigation of patients with possible bleeding disorders Anita Woolley Received Received
  110-PO-W Iliopsoas haemorrhage in children with factor XIII deficiency davut albayrak Received Received
  111-P-M Recovery and Half Life of Factor VIII Basak Koc Received Received
  112-P-M Cut-off value of the Bethesda assay and detection of low titre inhibitors in previously untreated children with severe haemophilia A Helen Platokouki Received Received
  112-PO-T Management of pregnancy in a woman affected with type 2B VWD eugenia biguzzi Received Received
  113-PO-W Successful use of Recombinant Factor VIIa for menorrhagia control in a patient with Glanzmanns thrombasthenia soeun Jun Received Received
  113-PO-T Clinical characteristics and laboratory findings in VWD pediatric patients in Colombia Javier Mauricio Cortes Bernal Received Received
  113-P-M Evaluation of Sensitivity of Factor Activity Assay Derived from Trubidimetric Clotting Curve Analysis Jaewoo Song Received Received
  115-PO-T Extending Surveillance of Tolerability and Treatment Efficacy in von Willebrand disease first results of the new Wilate-STATE study Anja Markert Received Received
  115-PO-W Development in the management of congenital factor XIII deficiency with factor XIII concentrate Narges beigom Mirbehbahani Received Received
  115-PO-M Monitoring of anti-platelet therapy: A comparison of methods Thomas Scholz Received Received
  116-PO-T The Nuss procedure (minimally invasive repair of pectus excavatum) in patients with von Willebrand disease case report Mirjana Mitrovic Received Received
  116-PO-W Rare factor deficiencies and circumcision:Cukurova Experience Ilgen Sasmaz Received Received
  117-PO-W Vitamin K Prophylaxis In A Child Of Hereditary Combined Deficiency Of Vitamin K-Dependent Clotting Factors. MURAT SOKER Received Received
  118-P-W Four years experience in a population of patients with hemophilia: musculoskeletal comprehensive approach Hermes Abreo Received Received
  118-P-M Characterization of Rare Hemostatic Disorders by Sanger Sequencing Sandy Krouwel Received Received
  119-PO-T Liver transplantation in type 3 von Willebrand disease Silva Zupan&269;i&263; Alek Received Received
  119-P-W Radioisotope synovectomy in severe hemophiliac patients with chronic synovitis in target joints:The six years experience of Cukurova University, Medical Faculty Hemophilia Team Bulent Antmen Received Received
  120-P-T Identification of socio-cognitive factors of adherence to treatment in children and adolescents with hemophilie Sarah Bérubé Received Received
  120-P-W Radiosynoviortesis with suspension 32p chromic phosphate Cuban. Baganet Cobas Aymara María Received Received
  121-P-M An int22h-related deletion combined with unbalanced X-chromosome results in severe haemophilia A in a female Behnaz Pezeshkpoor Received Received
  121-P-T FIVE YEARS OF COMPREHENSIVE ATTENTION: APPLYING THE WORLD FEDERATION OF HEMOPHILIA RECOMMENDATIONS. Monica Colonia Received Received
  121-P-W hemophilic pseudotumor BASTAR ACOSTA ARIOSTO Received Received
  122-P-T Max, the frog: an educative tool for toddlers with hemophilia Muriel Vercauteren Received Received
  122-P-W Factor VIII Deficient Mice Have Reduced Bone Mass: Chronic Effects of Factory Deficiency Without Injury and Acute Bone Loss in Injured Joints Ted Bateman Received Received
  123-P-W Total knee and hip replacement in hemophilia and related bleeding disorders Angelika Batorova Received Received
  123-P-T Patient and Caregiver Satisfaction with BAXJECT III, a Next-Generation Reconstitution System for AHF-rFVIII (ADVATE) Diane Ito Received Received
  124-P-W Successful treatment of pseudotumor in a patient with moderate hemophilia Ana Boban Received Received
  124-P-M Genotyping of a cohort of 12 HA families from Suriname Selene Schoormans Received Received
  125-P-M Identification of 13 previously unreported F9 gene mutations in hemophilia B subjects genotyped in the B-LONG clinical trial of rFIXFc Ekta Seth Chhabra Received Received
  125-P-W Multi modalitys for pseudotumour treatment in a severe haemophilia B patient wiht inhibitors Raul Bordone Received Received
  125-P-T An indirect comparison of the efficacy of prophylactic use of rFVIIIFc and other rFVIII products and model of the effect of compliance James Scanlon Received Received
  126-P-M Identification of 23 previously unreported FVIII mutations in severe hemophilia A subjects genotyped during the clinical trial of rFVIIIFc (A-LONG) Ekta Seth Chhabra Received Received
  126-P-T Perspectives of patients with haemophilia on adherence to prophylaxis: a grounded theory approach Liesbeth Schrijvers Received Received
  126-P-W Fractures in patients with haemophillia: our experience over 27 years Horacio Caviglia Received Received
  127-P-W Haemophilic pseudotumors treatment in patients with inhibitors Horacio Caviglia Received Received
  127-P-M Molecular Pathology of Haemophilia A in patients from Western India Shrimati Shetty Received Received
  127-P-T Drug Facility for support in the treatment of patients with hematological disorders in IPS Integral Medellin Colombia Natalia Valenzuela Lopez Received Received
  128-P-T Using closed loop reporting to change patient behaviour: Case report Robyn Shoemark Received Received
  128-P-W Arthroscopic Synovectomy for Hemophilic Arthropathy of Hemophiliacs in Taiwan Chia-Yau Chang Received Received
  129-P-T Surveillance for Hemophilia Inhibitors in the United States Mike Soucie Received Received
  129-P-W Functional outcome in flexion knee treated with botulinum toxin type A in patients with Haemophilia Carla Daffunchio Received Received
  130-P-W Ankle impingement: arthroscopic treatment of anterior osteophyte in patients with haemophilia Ana Douglas Price Received Received
  130-P-M Sustained FVIII Expression in Human Mesenchymal Stem Cells Derived from Chorionic Villus Sampling Maricel Miguelino Received Received
  131-P-T Prevention of dental injuries and management of first-aid procedures in Hemophilia A (HA) children: experience of a single center. VALERIA DE PADUA Received Received
  131-P-W Long term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: whats happened after 30 years follow up? Ghidelli Nicola Received Received
  132-P-T Dental Care Pathway for Children with Inherited Bleeding Disorders Franchesca Fong Received Received
  132-P-W Spectrum of involvement and quantitative limitations in the four commonly affected joints in 478 haemophilia patients in Northern India NARESH GUPTA Received Received
  132-P-M Circumcision and complications in adolescent and adult patients with hemophilia in southern part of Turkey: Cukurova experience Bulent Antmen Received Received
  133-P-W Circulating biochemical markers of acute joint bleeding in a mouse hemarthrosis model Narine Hakobyan Received Received
  133-P-T Dentistry five Years Experience Medellí Colombia Luz Helena Jaramillo Received Received
  133-P-M GENETIC BACKGROUND AND RISK OF POSTPARTUM HEMORRHAGE: RESULTS FROM AN ITALIAN COHORT OF 3,219 WOMEN eugenia biguzzi Received Received
  134-P-T Five years of comprehensive attention:Dentistry Luz Helena Jaramillo Received Received
  134-P-M IgG autoantibodies in plasma of acquired TTP patients and healthy individuals share common linear epitopes on ADAMTS13 Peter Turecek Received Received
  134-P-W Factors influencing the range of motion for total knee arthropathy in hemophilic patients Jun Hirose Received Received
  135-P-T Oral management of intraoral bleeding and postoperative infection of cystectomy in a case with a Hemophilia A Takashima Morihiko Received Received
  135-P-M Desmopressin does not lead to early hypertension Nanda Uitslager Received Received
  136-P-T Innovation from Bedside: Making of Effective and Safe Toothbrush Tailor-made at Clinic for Hemophiliac People Living with Joint Dysfunction Yumiko Nakagawa Received Received
  136-PO-M Does bad weather have a bad influence on joint bleedings in patients with haemophilic arthropathy? Teruhisa Fujii Received Received
  137-P-T Oral condition improving with dental extraction in two children with congenital bleeding disorders in Madagascar Simone Rakoto Alson Received Received
  137-PO-M Arterial thrombosis in severe hemophilia A: a case report and reviews of the literature Sihem KEBAILI Received Received
  137-P-W An evaluation of whether the ankle is now the dominant site of chronic hemophilic arthropathy in young adults with severe hemophilia. Shannon Jackson Received Received
  138-PO-M EFFICACY OF ANKAFERD BLOOD STOPER (ABS) IN PROPHYLAXIS AND TREATMENT OF ORAL MUCOSITIS IN PEDIATRIC MALIGNANCIES: A PILOT STUDY Turkan PATIROGLU Received Received
  138-P-T Dental therapy with ferrous sulphate to 15.5 in a patient with a Factor VII deficiency Marco Antonio Rueda Ventura Received Received
  138-P-W Application of local air cryotherapy(LAC) in complex treatment of acute hemarthrosis at hemophilia patients. Katsiaryna Kabaeva Received Received
  139-PO-M Usefulness of musculoskeletal ultrasonography of haemophilic arthropathy Ryota Hara Received Received
  139-P-W Radiological Evaluation of Patellofemoral Joint in Hemophilic Arthropathy Elcil KAYA BICER Received Received
  140-P-T Educational project: building multi-professional network for haemophilia patients dental care access in Lithuania Ruta Zaliuniene Received Received
  140-P-W A combined ultrasonographic and simple radiographic study for hemophilic arthropathy Jae-Hyung Kim Received Received
  140-PO-M Report of 3 hemophilia cases in Panamas aborigine population GUADALUPE VIVERO Received Received
  141-P-M Improving inter-observer variability of the Pettersson score using a consensus atlas Wouter Foppen Received Received
  141-P-W Long-term results of radiosynovectomy in the treatment of haemophilic synovitis: Istanbul Experience Basak Koc Received Received
  141-PO-T Prevention Treatment in Patients with Hemophilia Parreira Miryam Received Received
  142-PO-T Orthodontic Therapy Miryam Parreira Received Received
  143-P-T Global utilization of the International Prophylaxis Study Group (IPSG) Physical Therapy Hemophilia Joint Health Score (HJHS) Education Web-site Module Audrey Abad Received Received
  143-P-W Correlation between Ultrasonographic Score and Clinical Variables in Hemophilic Knee and Ankle Arthropathy Tsung-Ying Li Received Received
  143-P-M Outcomes measures in patients with haemophilia: Survey of implementation in routine clinical practice and perception of relevance by European treaters of the EHTSB Cedric HERMANS Received Received
  144-P-M The Impact of Social Status of Adult Haemophilia Patients from a Single German Treatment Centre on Outcome Parameters Katharina Holstein Received Received
  144-P-W THE HEMOPHILIA JOINT HEALTH SCORE (HJHS) IN CHILDREN WITH HEMOPHILIA DURING PROPHYLAXIS IN COLOMBIA. EXPERIENCE OF TWO CENTERS. Adriana Linares Received Received
  144-P-T Innovative teaching tool for young children with severe hemophilia Claudine Amesse Received Received
  145-P-T The Effects of Human Potential Development Seminar (HPDS) for Hemophilic arthritis patients Won Sook Bak Received Received
  145-P-W JOINT DAMAGE AND BLEEDING IN THE HIP BY ULTRASONOGRAPHY Silvia Linari Received Received
  145-P-M Interim AHEAD Study Results: Long-term ADVATE Outcome Database on Joint Health, HRQoL, Annualized Bleeding Rates, and Individualized Treatment Alexandra Loew-Baselli Received Received
  146-P-T Translation of a Haemophilia poster into ten official languages Alice Banza Received Received
  146-P-W The importance of joint ultrasound to improve adherence to treatment in children and adolescents with Hemophilia Marta Milan Received Received
  147-P-W Extended factor IX activity improves joint healing in Hemophilia B mice Paul E Monahan Received Received
  147-P-M The Association Between Physical Activity and Bleeding In Persons with Hemophilia: An Examination of Existing Evidence and Recommendations for Future Research Elizabeth Schwartz Received Received
  148-P-M Correlation between the Hemophilia Joint Health Score (HJHS 2.1) and the number of previous joint bleeds in children with hemophilia: preliminary results. Fabio Souza Received Received
  148-P-T Oscar: A Tool for Therapeutic Education to Approach the Pharmacokinetic Concepts in Hemophilia Valérie Chamouard Received Received
  150-P-T DISCOVERING HAEMOPHILIA Stephanie Delienne Received Received
  150-P-M How to Assess Adherence in Haemophilia Patients? Sylvia von Mackensen Received Received
  151-P-T The creation and implementation of a nursing fellowship in bleeding disorders Floros Georgina Received Received
  153-P-T Using Oral History for Patient Education: The Gift of Experience II: Conversations with Parents about Hemophilia Laura Gray Received Received
  153-PO-M Intracranial Haemorrhage in Patients with Haemophilia and Outcome Basak Koc Received Received
  154-PO-M ANNUAL BLEEDING RATE AS OUTCOME DURING PROPHYLAXIS IN CHILDREN WITH HEMOPHILIA IN A LIMITED RESOURCES COUNTRY. EXPERIENCE OF TWO CENTERS. Adriana Linares Received Received
  155-P-W RADIOISOTOPE SYNOVECTOMY IN PATIENTS WITH HAEMOPFILIA: SINGLE CENTER EXPERIENCE Turkan PATIROGLU Received Received
  155-PO-M EVALUATION OF FUNCTIONAL COMMITMENT USING FISH TEST OF CHILDREN WITH HEMOPHILIA RECEIVING PROPHYLAXIS Adriana Linares Received Received
  156-P-T Retrospective identification of factors which contribute to Hepatitis C treatment decisions in a population of people with haemophilia in Ireland Declan Noone Received Received
  156-P-W Outcome after Total Knee Arthroplasty in Haemophilic Patients with Stiff Knees Peter Pennekamp Received Received
  156-PO-M OUTCOMES IN PEDIATRIC HEMOPHILIA TREATMENT CENTERS IN A DEVELOPING COUNTRY. BEYOND THE REQUIREMENT. Adriana Linares Received Received
  157-PO-M Hemophilia and Von Willebrand disease home care program in Colombia: a 7 years experience Cesar Montaño Received Received
  157-P-T The impact of school visits by multidisciplinary team in the integration of children with hemophilia in recreational and physical activities at school MARGARETH OZELO Received Received
  157-P-W Results of ankle prosthesis in patients with severe haemophilic arthropathy follow up Manuela Krause Received Received
  158-P-M Conservative management of an acute spinal epidural hemorrhage in a child with hemophilia A with inhibitor Ali Bay Received Received
  158-P-T Motivational Interviewing and Health Behavior Change: An Educational Intervention for Healthcare Professionals Barbara Perry Received Received
  159-P-M Comparison of increase in FVIII levels with exercise and DDAVP challenge: results from the SickKids hemophilia exercise study Vanessa Bouskill Received Received
  160-P-W How to evaluate the state and the progress of haemophilic joints with no or only mild haemarthropathy in routine and research Axel Seuser Received Received
  160-P-M Inter-reader reliability of minimum and full MRI protocols for interpretation of findings in hemophilic arthropathy in children Denise Castro Received Received
  161-P-W Effects of haemophilic arthropathy and age on subjective physical performance in people with severe haemophilia Franziska Stuber Received Received
  161-P-M Current diagnosis status of Children with hemophilia in China. An analysis of Single center data including 417 cases of children with hemophilia in 13 years. Zhenping Chen Received Received
  162-P-T Preparing Gelatin as a Pedagogical Tool for Teaching Cryotherapy in Hemophilia Claudia Sofia Taboada Saavedra Received Received
  163-P-W From Sitting to Walking: Bilateral Total Knee Replacements for a Hemophilia patient with Inhibitor a Case Study Rachel Tiktinsky Received Received
  163-P-M Long-term evaluation of radioisotope synovectomy with Yttrium 90 and rhenium186 for chronic synovitis in Turkish haemophiliacs: Akdeniz University experience. Alphan Kupesiz Received Received
  164-P-M Experience of Prophylaxis with Activated Prothrombin Complex Concentrate in A Child with Hemophilia B and Inhibitor Alphan Kupesiz Received Received
  165-P-W Elective major surgery in haemophiliacs: Istanbul experience Gulen Tuysuz Received Received
  165-P-M Use of central venous catheters in children with haemophilia: long term investigations in Poland pawel Laguna Received Received
  165-PO-T EGE HAEMOPHILIA SCHOOL: THE COURSE OF DEPRESSION FOR ADULT HAEMOPHILIA PATIENTS AND RELATIVES, EVALUATION OF THE EFFECTIVENESS BY PRETEST AND POSTTEST Fahri Sahin Received Received
  166-P-M Diagnostic and Management Delays in Children with Haemophilia Presenting with Intracranial Haemorrhage JOYCE CHING MEI LAM Received Received
  166-P-W Interleukin-1beta is essential for blood-induced cartilage damage in vitro Lize van Vulpen Received Received
  166-PO-T EXPERIENCE PROGRAMS PARENTS EDUCATING PARENTS IN THE CONGENITAL COAGULOPATHY CLINIC PANAMA. LUZ VILLALAZ Received Received
  167-PO-T EVALUATION OF TRAINING FOR FAMILIES OF PATIENTS WITH CONGENITAL COAGULOPATHIES PANAMA 2012 -2013. LUZ VILLALAZ Received Received
  167-P-W Acute hemarthrosis in hemophilic mice results in expansion of mesenchymal progenitor cells: a novel mechanism of arthropathy Annette von Drygalski Received Received
  167-P-M Assessment and validation of a defined fluid restriction to prevent hyponatremia following the use of subcutaneous desmopressin (DDAVP) for children with inherited bleeding disorders Jane Mason Received Received
  168-P-M Description of consultations by hemophiliac patients in the Hospital Center Pereira Rossell pediatric emergency department. Montevideo. Uruguay. ROSSANA MEZZANO Received Received
  168-P-W Validation of the HEP-Test-Q for the Assessment of Subjective Physical Performance in English-Speaking Haemophilia Patients Sylvia von Mackensen Received Received
  168-P-T The Global health of Children with Hemophilia and Its Related Factors, Shiraz-Iran Noushin Beheshtipoor Received Received
  169-P-T Understanding how patients, physicians and the general population value different types of hemophilia therapies and their willingness-to-pay for such therapies: a discrete choice experiment from the US perspective. Shraddha Chaugule Received Received
  169-P-W Bone mineral density and bone turnover markers in children with Haemophilia A PANAGIOTA XAFAKI Received Received
  169-P-M Pharmacokinetics (PK) of recombinant and plasma-derived factor IX (FIX) products in pediatric patients with severe hemophilia B Kim Nagel Received Received
  170-P-W Chemical Synovectomy with Rifampicin for Hemophilic Arthropathy in Korea Ki-young Yoo Received Received
  170-P-M Arterial pseudoaneurysm in hemophilia patient; successful result of non-invasive treatment, clotting factor replacement and US-guided compression Young Shil Park Received Received
  171-P-T Appointment No-show Rates How One Hemophilia Team Tackled This Significant Problem Deborah Gue Received Received
  171-P-M Surgical procedures as a risk factor for the inhibitor development in young children with Haemophilia Rosemarie Schwyzer Received Received
  172-P-W Illeopsoas bleeds--- Challenges in a developing country TAHIRA ZAFAR Received Received
  172-P-T Employment and workplace issues in haemophilia in Northern India- a review of 95 case studies NARESH GUPTA Received Received
  173-P-M Clinical Characteristics and Treatment of Iliopsoas Hematoma Episodes in Pediatric Patients with Hemophilia, A Single Center Experience Emine Trkkan Received Received
  173-P-T The disability adjusted life years (DALYs) and economic burden due to haemophilia in Belgium Séverine Henrard Received Received
  174-PO-W Orthopaedic surgery in Haemophiliac patients: Our experience in Canada Stuart Bisland Received Received
  174-P-M A Very Unusal Bleeding Site of Hemophilia: Nasal Septal Hematoma AYSEGUL UNUVAR Received Received
  174-P-T Measuring parental work absence associated with factor concentrate administration in children with hemophilia in the United States Hemophilia Utilization Group Study Part V (HUGS V) Xiaoli Niu Received Received
  175-PO-M Central Nervous System Hemorrhage in Bleeding Disorders Nihal Ozdemir Received Received
  175-P-T Estimating the potential cost of bypassing agent prophylaxis relative to the cost of rFVIIa on-demand using actual rFVIIa doses from multiple US registries Abiola Oladapo Received Received
  175-PO-W Knee joint bleeding history and abnormal inter-extremity difference (AIED) of quadriceps strength in people with severe haemophilia Alexander Brunner Received Received
  176-PO-M Variables of success in ITI (immunotollerance induction) in pediatric patients with severe Hemophilia A. Unpredictability due to reasons not related with the FVIIIs mutation, type of concentrate and with inhibitor peak Fabio Gagliano Received Received
  177-PO-W Elbow arthropathy in severe haemophilia: a challenge of prevention and treatment Nicola Ghidelli Received Received
  177-P-W The role of biomarkers of joint damage in monitoring the efficacy of different prophylaxis regimens for severe haemophilia Irena Djunic Received Received
  177-P-T INCIDENCE AND SOME CHARACTERISTICS OF PATIENTS WITH HAEMOPHYLLIA IN BOSNIA AND HERZEGOVINA Jelica Samardzic Predojevic Received Received
  177-PO-M Successful treatment of intracranial haemorrhage after trauma in a child with severe haemophilia A and factor VIII inhibitor Murat Soker Received Received
  178-PO-W Using Soft Tissue Ultrasound in Post-operative Assessment following Arthroscopic Synovectomy in Hemophilic Arthropathy Jiunn-Horng Kang Received Received
  178-PO-M Hereditary Factor Deficiencies: A Review of Twenty Years Experience in a Pediatric Hematology Unit, Istanbul , Turkey Emine Trkkan Received Received
  178-P-T Treating pregnant women with high dose immunoglobulin (IVIG) in a single skilled Center reduce side effects Dalia Bashari Received Received
  179-PO-W Three repeated Radioisotope Synovectomy injections for same resistant joint with chronical synovitis in 14 patients with hemophilia Kaan Kavakli Received Received
  179-PO-M Successful thrombolysis with Enoxaparin in two pediatric patients presenting with intracardiac and cerebral thrombosis Gesa Wiegand Received Received
  180-PO-W Turkish experience in Radioisotope Synovectomy; Efficacy and safety for three joints of application during one session in patients with hemophilia Kaan Kavakli Received Received
  180-P-T Major surgery in severe haemophilia A with inhibitors using a NovoSeven/FEIBA hybrid regimen Caryl Lockley Received Received
  181-P-T Managing the unpredictable: challenges in severe Factor X deficiency Caryl Lockley Received Received
  181-P-M Speaking as One Voice: Uniting and Educating Advocates Erin Couch Received Received
  181-PO-W Results of a Delphi Consensus Exercise on Potential Contributory Factors for the Development of Ankle Haemarthropathy Ann McCarthy Received Received
  182-P-T Professionalization of Haemophilia Nurse Practitioners: Introducing a Peer Review Group Greta Mulders Received Received
  182-P-M Patients Perspective of Care at the US Federally Funded Hemophilia Treatment Centers Ann Forsberg Received Received
  183-P-T Total Femur and total knee replacement in a Patient with Severe hemophilia A and history of high titer factor VIII inhibitor, HIV and hepatitis C: A Case Study Rosanne Ososki Received Received
  183-P-M Judicial recognition for obtaining treatment Daniel Adolfo Luna Received Received
  184-PO-W SURGICAL MANAGEMENT OF PSEUDOTUMORS IN PATIENTS WITH HEMOPHILIA AURO VISWABANDYA Received Received
  184-P-T Taking over prophylactic treatment: Assessment of the transition process in haemophilia Liesbeth Schrijvers Received Received
  185-PO-W Surgery for musculoskeletal complications in patients with Hemophilia. AURO VISWABANDYA Received Received
  185-P-M An Evaluation of a Canadian Transition Program: From Pediatrics to Adult Care Vanessa Bouskill Received Received
  185-P-T A developing aspect of Hemophilia nursing: the role nurses play in clinical trials Senol Selmin Received Received
  186-P-M Increasing cohesion in a province with 9 Hemophilia Treatment Centres through a central coordinator. Sarah Crymble Received Received
  186-P-T Comparing Similar and Diversified Treatment Modalities in Hemophilia Patients with Post-Operative Dental Complications Lisa Thibeault Received Received
  187-P-W Recovery of the gait ability after total knee arthroplasty Minoru Kubota Received Received
  187-P-M Continuous Quality Improvement for Continuous Factor Infusion Georgina Floros Received Received
  187-P-T Coronary bypass surgery in a patient with hemophilia A: The critical role of the nurse clinician Dawn Zawadski, RN, BN Received Received
  188-P-W Hydrotherapy for severe hemophilia patients in Korea sejin kwon Received Received
  188-P-M A universal outcome measurement system for improving care in haemophilia: Hemophilia Success Scorecard (HSS) Richard Littlewood Received Received
  189-P-M A comprehensive review of current haemophilia care and outcomes in Singapore Heng Joo Ng Received Received
  189-P-W The Use of Custom Orthoses (Braces) for Pain Management in Hemophilic Arthropathy: Two Case Studies Naomi Matsui Received Received
  189-PO-T Effect of Care of Hemophiliacs in Nan province , Thailand under limited of resources in Universal Coverage Scheme. Jurarat Suriyathai Received Received
  190-PO-T A single centre experience with venous access devices in pediatric Hemophilia A patients with inhibitors Celina Woo Received Received
  190-P-W Evaluation of a Portuguese version of the Functional Independence Score for Hemophilia (FISH) in the Brazilian population MARGARETH OZELO Received Received
  190-P-M Physical Design of a Hemophilia Society Center : An Example From Turkey Yusuf Buyukp&305;narbasili Received Received
  191-P-W Surface electromyography evaluation in patients with hemophilia undergoing swimming classes MARGARETH OZELO Received Received
  191-P-T Social Representations of People With Haemophilia in the United States and the United Kingdom Laura Palareti Received Received
  192-P-W Physical Activity in Adults with Severe Hemophilia: A Feasibility Study Sandra Squire Received Received
  193-P-W Reliability of Hemophilia Joint Health Score (HJHS) version 2.1 in person with hemophilia Merlyn Tilak Received Received
  193-P-T Strategies by Japanese Mothers of Children with Hemophilia Regarding Hemophilia Disclosure at School Yukiko Seki Received Received
  193-P-M Development of the Hemophilia Clinic Directors Group in Canada: An Oral History Robert Card Received Received
  194-P-M Three roles, one magnificent outcome: the organizational successes of an integrated camp experience in Ontario, Canada. Sarah Crymble Received Received
  194-P-T Spaces for mothers Daniela Maria Belen Serpa Received Received
  195-P-M Schools and Hemophilia: achievements of the Catalan Association of Hemophilias pedagogical intervention Ana Maria Fernández Received Received
  196-P-T Modifiers of self-efficacy in patients with hemophilia Duc Tran Received Received
  196-PO-W The Use of Kinesio Tape in The Management of Acute Musculoskeletal Bleeds in Haemophilia David Hopper Received Received
  196-P-M Factor Assistance Program Utilization: A Follow-Up Study among Patients Attending the Gulf States Hemophilia and Thrombophilia Center (GSHTC) in Houston, Texas Between 2011 2013 Aroub Khleif Received Received
  197-P-T Thats life (with hemophilia): A qualitative analysis of young mens experiences of change. Nancy Young Received Received
  197-P-M RED LAPI: Committed to improve bleeding disorders care in Latin-America Shannely Lowndes Received Received
  197-PO-W Arthroscopic ankle synovectomy improves not only ankle pain and ROM but also the distribution of planter pressure in haemophilia patients Megumi Noguchi Received Received
  198-P-M Changes in hemophilia treatment in Bolivia after joining the World Federation of Hemophilia (WFH) Shannely Lowndes Received Received
  198-P-T Impact of Significant Life Events on HRQoL in Haemophilia Nancy Young Received Received
  199-PO-T Play Therapy for children with Bleeding Disorders Priyanka Rawat Received Received
  199-P-M The UK Haemophilia Centre Doctors Organisation Genetic Laboratory Network - a valuable resource for the development and standardisation of genetic testing in individuals with hereditary disorders of haemostasis Gillian McGaffin Received Received
  199-PO-W Drastic improvement of activities of daily life (ADL) from wheelchair confinement to walking with bilateral axillary crutches: combination of physiotherapy and treatment with recombinant factor VIIa in a haemophilia B patient with inhibitors. Akiko Shimokawa Received Received
  200-P-M The History of Hemophilia Community in Japan Ryusuke Sano Received Received
  200-P-W What is known about care of a newborn with hemophilia? Kay Decker Received Received
  201-P-W The UK Buddy Award Swimming Academy Daniel Hart Received Received
  201-P-M Winnipeg-Delhi: Reflections on a Twinning partnership Jayson Stoffman Received Received
  202-PO-T Exploring Psycho-Social Provision Across a Network of Three Haemophilia Comprehensive Care Centres Nicola Dunn Received Received
  202-P-M Lessons in the development of Haemophilia Care and Outreach Rajendra Thejpal Received Received
  203-PO-W Reiki As Complementary Approach For Pain Relief In Patients With Haemophilia And Chronic Arthropathy: A Pilot Study. Maria Elisa Mancuso Received Received
  204-P-W Managing Haemophilia at a distance- polytrauma in a patient with severe haemophilia A. A multidisciplinary case review. Paul McLaughlin Received Received
  204-P-M Data Managers Group (DMG) the powerhouse behind Australian Bleeding Disorder Registry (ABDR) Deirdre Tuck Received Received
  205-P-M UPLIFT PROGRAMS ACTIVITY OF HEMOPHILIA CARE OF PAKISTAN IMRAN ZIA Received Received
  205-P-W A Project to Decrease Day of Surgery Wait Time for Children with Bleeding Disorders Judy Kauffman Received Received
  206-P-T Self infusion and home treatment in hemophilia: experience of the hematology department of Constantine, Algeria Sihem KEBAILI Received Received
  206-P-M Hemophilia Summer Camp Modelling Based On A Concept (MOCC): An Example From Turkey Haluk zulfikar Received Received
  206-P-W The UK Buddy Award Swimming Academy Lori Laudenbach Received Received
  207-P-W Pain Management: Do We Offer Appropriate Care for Men With Pain Due to Hemophilic Arthropathy? Michelle Sims Received Received
  207-P-T Evolving the Pediatric Homecare Infusion Program: A Canadian Experience Vanessa Bouskill Received Received
  207-PO-M My experience as an Accompanying Parent Soledad Rivero Haedo Received Received
  208-P-T Achieving Independence: Providing Patients with the Tools to Manage their Care Erin Couch Received Received
  208-P-M Five years of comprehensive attention: Applying The World Federation of Hemophilia recommendations. Mauricio Jaramillo Received Received
  208-PO-M Grandparents and hemophilia: something more than just assessment Adolfo Rodríguez Received Received
  209-P-W Parenting and Care of a Child with Hemophilia: the Interest of Autonomy Support to Develop New Psychosocial Interventions Sarah Bérubé Received Received
  209-P-T Your Inhibitor Treatment Plan and You: Is your treatment working for you? Kay Decker Received Received
  210-P-M Love, Sexuality and Communication in Hemophilia: A Psychosocial and Patient Perspective Book Developed for Adolescents, Adults, and Carriers FREDERICA CASSIS Received Received
  210-P-T An infusaport education package - addressing the needs of parents Janine Furmedge Received Received
  211-P-M Nutritional assessment and adherence to treatment of Hemophilia A and B patients in Integral IPS Medellin Colombia Gloria Marcela Echeverri Hincapie Received Received
  211-P-T Knowledge of Disease and Treatment Understanding among Patients with Hemophilia: Interim Results among Patients Attending the Gulf States Hemophilia and Thrombophilia Center (GSHTC) Aroub Khleif Received Received
  212-P-T Moba-Roku: use of a mobile recording system for tracking treatment infusions Kentaro Nishimura Received Received
  212-P-M Surviving and Thriving: Living with von Willebrands Disease and Platelet Aggregation Dysfunction Julie Heinrich Received Received
  213-P-W Fathers and Mothers Perceptions and Communication on Carrier Status and Diagnosis of Congenital Haemophilia: Global Results From the Haemophilia Experiences, Results and Opportunities (HERO) Study Frederica Cassis Received Received
  213-P-M The Good Life: Quality of Life among Danish PWBD Karen Holm Received Received
  214-P-M The Effect of Characteristics of Patients with Hemophilia on the Quality of Life SANG CHUN JU Received Received
  214-P-W Social Desirability Of Hemophiliac Children Gentjana ekani Received Received
  215-P-W Input of a multidisciplinary management approach in announcing the diagnosis for young children with serious constitutional hemorrhagic disease and their families CHAMBOST HERVE Received Received
  215-P-T Teaching Self Infusion With the KitK Kit in the Camp Setting Susan Van Oosten Received Received
  215-P-M Psychosocial functioning and health related quality of life of boys with hemophilia 8-12 years Perrine Limperg Received Received
  216-P-M Systematic review of clinical trials results assessing health-related quality of life in hemophilia patients receiving prophylaxis Abiola Oladapo Received Received
  216-P-W Social Participation and Hemophilia in Boys Under 18 Years of Age Living in Ontario, Canada Aubrey Chiu Received Received
  216-P-T The advantage of art activities in assisting hemophilia children to cope with intravenous factor concentrate injection Pakawan Wongwerawattanakoon Received Received
  217-PO-T Issues with central venous access devices (CVAD) : example of a young boy with severe hemophilia B Muriel Vercauteren Received Received
  218-P-W Patient-led Awareness Raising Activities as Tool in Increasing Initial Diagnosis for People Bleeding Disorders Based on Family History When Laboratory Tests are Not Available Andrea Echavez Received Received
  218-PO-T SELF INFUSION IN PEPOPLE WITH SEVERE HEMOPHILIA IN CONGENITAL COAGULOPATHIES CLINIC IN THE LAST 10 YEARS IN PANAMA. LUZ VILLALAZ Received Received
  218-P-M Functional Independence Score in Haemophilia: Ege University Adult Haemophilia Center Experience Fahri Sahin Received Received
  219-P-W Results of a Transition questionnaire: From pediatric to adult hemophilia care Petra Elfvinge Received Received
  220-P-M Interpreting Important Health-Related Quality of Life Data Changes from Baseline Using the Haem-A-QoL to Define Responders Among Individuals With Hemophilia James Scanlon Received Received
  221-P-M Health-Related Quality of Life Data Changes Over Time Using Haem-A-QoL Scores in the B-LONG Clinical Study of Recombinant Factor IX Fc Fusion Protein James Scanlon Received Received
  221-P-T Factor VIIa-CTP, a novel long-acting coagulation factor proposing an improved prophylactic and on demand treatment of hemophilic patients, extensive invitro characterization in preparation for First in Human Study Hart Gili Received Received
  221-P-W WhatsApp a new instrument for support in Hemophilia care Gina Goldstein Received Received
  222-P-W Psychosocial Issues in 570 Patients with Haemophilia from Northern India NARESH GUPTA Received Received
  222-P-M The Trajectory of Health-Related Quality of Life in Youth and Men with Hemophilia A Jean St-Louis Received Received
  222-P-T Safety and efficacy of Factor VIIa-CTP, a novel long-acting coagulation factor proposing an improved prophylactic and on demand treatment of hemophilic patients in preparation for First in Human Study Hart Gili Received Received
  223-P-M Factors Influencing Quality of Life in Chinese Adults with Haemophilia: Results from the HERO Study Jing Sun Received Received
  223-P-W Addressing the Sexual Wellbeing Needs of Adolescents with Haemophilia April Jones Received Received
  223-P-T Elucidation of structure and functional characteristics of OBI-1, a recombinant, porcine sequence FVIII Jocelyn Hybiske Received Received
  224-P-W Hemophilia Social Workers: Roles, Supervision and Support Needs Ellen Kachalsky Received Received
  224-P-M Self Infusion: Achieving Independence With The Added Challenge of Autism Susan Van Oosten Received Received
  224-P-T Assay Management for the Treatment of Hemophilia A and B: Experience from the Gulf States Pharmacy (GSP) Aroub Khleif Received Received
  225-P-M Development of a First Hemophilia-Specific Burden Scale for Caregivers of Children with Hemophilia in the US the HEMOphilia associated Caregiver Burden Scale (HEMOCABTM) Sylvia von Mackensen Received Received
  225-P-T Comparison of paper diary and B-CoNect (telemetric smartphone application) at home treatment monitoring of severe haemophilia A patients Patrick HOUETO Received Received
  226-P-T National Supply of Products for Bleeding Disorders in Australia Michael Stone Received Received
  226-P-M Associations of Mental Health Problems and Care Burden among Caregivers of Children with Hemophilia A and B with and without inhibitors Tami Wisniewski Received Received
  226-P-W The Study on Stress and Social support of the Mother with Hemophilic child yunjeong kim Received Received
  227-P-T A provincial redistribution system to prevent wastage of clotting factor concentrates: 6.5 year update Jerome Teitel Received Received
  227-P-W Reliability, validation and evaluation of the Hemophilia Coping and Perception Test Perrine Limperg Received Received
  228-P-T Overview of the structure and manufacturing process for OBI-1, a recombinant porcine sequence, factor VIII for the treatment of acquired hemophilia A Peter Wojciechowski Received Received
  228-PO-M Use of home videos to communicate significant changes Cheryl DAmbrosio Received Received
  228-P-W Hemophilia and Mental Health in Integral IPS Medellin Colombia Jorge Luis López García Received Received
  229-P-T Open versus Closed Social Networking Groups Cheryl DAmbrosio Received Received
  229-P-W Sex life and self-esteem in adults with haemophilia Marko Marinic Received Received
  229-PO-M A Study of Art and Breathing Activities for Children with Hemophilia EKAWAT SUWANTAROJ Received Received
  230-P-W Barrier Assessment in Establishing Comprehensive Client-Level Coordination for Treatment and Medical Welfare of People Living with Hemophilia and HIV/AIDS in Japan Miwa Ogane Received Received
  230-P-M Haemophilia News: The Use of Facebook, a social Network to Inform Patients with Hemophilia Uwe Schlenkrich Received Received
  230-P-T The Self-BAT (Self-administered Bleeding Assessment Tool) is an Effective Screening Tool for von Willebrand Disease in Women Referred to Hematology Julie Grabell Received Received
  231-P-W Biopsychosocial impact on families patients with hemophilia Maricela Osorio-Guzmán Received Received
  231-P-M STATISTICAL EVALUATIONS ON THE INTERNET USAGE BEHAVIOUR OF THE INDIVIDUALS WITH HAEMOPHILIA IN TURKEY Haluk Zulfikar Received Received
  232-P-M Summer educational and sports training for young people 8-14 years Herman De Smet Received Received
  232-P-W Self- esteem levels in hemophilia Mexican carriers Maricela Osorio-Guzmán Received Received
  232-P-T Men Helping Women An Empowerment Approach to Create Women Leaders Indira Nair Received Received
  233-P-T Worldwide Awareness of Women with Bleeding Disorders through Videos Carol Nave Received Received
  233-P-M Strategies to optomise inclusion and involvement of Young Men with Haemophilia Declan Noone Received Received
  234-P-T Bleeding Phenotype And Provider Interventions For Menorrhagia In Post-Menarchal Adolescents With Congenital Bleeding Disorders (CBD) When Compared To Adult Women: A Surveillance Report Of The Female Universal Data Collection (UDC) Project In United State Lakshmi Srivaths MD Received Received
  234-P-M Development of a hemophilia youth group in New Delhi through the Manitoba-Delhi Twinning partnership Jayson Stoffman Received Received
  235-P-T Pregnancy management in inherited bleeding disorders Maria Vinogradova Received Received
  235-PO-W Five years of comprehensive attention: applying the world federation of hemophilia recommendations Victoria Eugenia Saldarriaga Cataño Received Received
  236-PO-M New identity markers of young PWBD - a challenge? Karen Holm Received Received
  236-P-T Such a bleeding nuisance: A qualitative study into the female patient experience of inherited bleeding disorders ANNE WAREING Received Received
  237-PO-T Woman with factor XIII deficiency : Safety and Pregnancy Inger Adamsen Received Received
  237-PO-M Building the Future Leaders in the Hemophilia Society:Summer Camps in Ontario,Canada Elizabeth Paradis Received Received
  238-P-M Hemophilia in developing countries: an analysis of the first data in Cameroon. Tayou Tagny Claude Received Received
  239-P-M Hemophilia management in development countries is a big challenge. Case of Mali West Africa. DIALLO Yacouba Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
01:03
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

WFH 2014 World Congress

 

11-15 May 2014 Melbourne
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 12/07/2014 TO 13/10/2020
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.WFH2014.2014 








PosterSessionOnline
Logo Draft
 
Logo Cert